cytosine has been researched along with pyridoxine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Penn, NW | 2 |
Fiol, JB | 1 |
Blom, HJ; Eskes, TK; Gabreëls, F; Smeitink, JA; Stevens, EM; Trijbels, FJ; van den Heuvel, LP; van der Put, NM | 1 |
Artuch, R; Campistol, J; Cardo, E; Colomé, C; Monrós, E; Pineda, M; Vilaseca, MA | 1 |
5 other study(ies) available for cytosine and pyridoxine
Article | Year |
---|---|
Ethanol antagonism by 5-hydroxymethyl cellular compounds.
Topics: Animals; Brain; Cytosine; Drug Combinations; Ethanol; Male; Mice; Pyridoxal; Pyridoxine; Sleep; Structure-Activity Relationship | 1975 |
Antagonism of barbiturate by DNA pyrimidines and allied compounds.
Topics: Animals; Barbiturates; Cytosine; Mice; Pyridoxine; Pyrimidines; Sleep; Thymine; Time Factors | 1975 |
[Taxonomy of the Pichia species: intracellular enzyme research; vitamin requirements; systematic consequences].
Topics: Ascomycota; Biotin; Carbohydrate Metabolism; Classification; Cytosine; DNA; Galactosidases; Glucosidases; Guanine; Phylogeny; Pyridoxine; Sucrase; Thiamine; Trehalase | 1974 |
A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?
Topics: Adenine; Adult; Cytosine; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neural Tube Defects; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prevalence; Pyridoxine; Vitamin B 12 | 1998 |
Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Cytosine; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Humans; Hyperhomocysteinemia; Infant; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic; Pyridoxine; Secondary Prevention; Stroke; Thymidine; Vitamin B 12; Vitamins | 2000 |